Our Opinion

ImmunoCellular Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, research and therapies.

Evidence:

This press release specifically mentions use of animal testing:
http://investors.imuc.com/releasedetail.cfm?releaseid=872320

Company Description

ImmunoCellular Therapeutics, Ltd.  is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The phase 3 registrational trial of lead product candidate, ICT-107, a patient-specific, dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells, has been initiated.

Company website:  http://www.imuc.com